Blog
RSS FeedPosted by Michael Wonder on 17 Oct 2017
Trump's new talk on U.S. drug prices sends biotech index down
17 October 2017 - President Donald Trump isn’t done talking about U.S. drug prices, and investors aren’t done worrying about ...
Posted by Michael Wonder on 17 Oct 2017
Swissmedic updates requirements concerning the fast-track authorisation procedure
16 October 2017 - On 1 October 2017, the Swiss Agency for therapeutic products updated its guidance document concerning the ...
Posted by Michael Wonder on 17 Oct 2017
Health Canada gives 'kiss of death' to planned policy for rare-disease drugs
16 October 2017 - The framework was announced by the Harper government in 2012, but sat on the back burner since ...
Posted by Michael Wonder on 16 Oct 2017
Trump administration weighs rollback of policy that supporters say helped lower drug prices
13 October 2017 - The Trump administration is considering rolling back an Obama-era policy that supporters say successfully lowered some ...
Posted by Michael Wonder on 16 Oct 2017
EMA’s business continuity plan for Brexit published
16 October 2017 - Plan aims to ensure continuity of Agency’s operations. ...
Posted by Michael Wonder on 16 Oct 2017
Where the FDA is going under Trump
15 October 2017 - Commissioner Scott Gottlieb says it isn’t about more or fewer regulations. It’s about efficiency. ...
Posted by Michael Wonder on 13 Oct 2017
Donald Trump’s health care orders will hurt middle-class, self-employed Americans
13 October 2017 - By starving Obamacare of cash, the White House is taking a political gamble. ...
Posted by Michael Wonder on 12 Oct 2017
Trump signs order to undermine Obamacare insurance rules
12 October 2017 - It could create a parallel insurance system for healthy people. ...
Posted by Michael Wonder on 12 Oct 2017
Health insurers’ billion dollar remedy
13 October 2017 - Australia’s health insurers have backed the most comprehensive reforms to hit the industry in almost 20 ...
Posted by Michael Wonder on 12 Oct 2017
Foiled in Congress, Trump moves on his own to undermine Obamacare
11 October 2017 - President Trump, after failing to repeal the Affordable Care Act in Congress, will act on his ...
Posted by Michael Wonder on 12 Oct 2017
Health fund premiums to be reined in under sweeping Turnbull government changes
12 October 2017 - Private health insurers will be able to charge higher excesses and offer discounts to under-30s under ...
Posted by Michael Wonder on 12 Oct 2017
First FDA approval agnostic of cancer site — when a biomarker defines the indication
11 October 2017 - In May 2017, the FDA approved pembrolizumab, a programmed death 1 inhibitor, for adult and paediatric patients ...
Posted by Michael Wonder on 11 Oct 2017
An FDA program to approve old drugs causes higher prices and shortages
11 October 2017 - In 2006, the FDA launched a program to require drug makers to win approval of medicines ...
Posted by Michael Wonder on 11 Oct 2017
Study finds significant overlap in the drugs covered by Canadian public drug plans
11 October 2017 - The Patented Medicine Prices Review Board, through the National Prescription Drug Utilisation Information System research initiative, ...
Posted by Michael Wonder on 11 Oct 2017
Statement by FDA Commissioner Scott Gottlieb on new steps by FDA to advance patient engagement in the agency’s regulatory work
11 October 2017 - The FDA is hosting a pioneering event today: the first meeting of the Patient Engagement Advisory ...